Cysteinyl leukotrienes as common mediators of asthma and allergic disease

Clinical and Experimental Allergy Reviews

Volumn 3, Issue 2, 2003, Pages 69-73

  Dahlen S E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allergy; Asthma; Leukotriene receptor antagonists; Leukotrienes

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MONTELUKAST; PEPTIDOLEUKOTRIENE; ZAFIRLUKAST; ZILEUTON;

AIRWAY OBSTRUCTION; ALLERGY; ASTHMA; BLOOD FLOW; BODY FLUID; CELL ACTIVATION; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; MUCUS SECRETION; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; URINE;

EID: 0038637953     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-9725.2003.00016.x     Document Type: Conference Paper

References (30)

1. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340:197-206.
2. Meltzer EO. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of 'one linked airway disease'. Ann Allergy Asthma Immunol 2000; 84:176-87.
3. Feldberg W, Kellaway CH. Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol 1938; 94:187-226.
4. Murphy RC, Hammarström S, Samuelsson B. Leukotriene C. A slow reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 1979; 76:4275-9.
5. Hedqvist P, Dahlén S-E, Gustafsson LE, Hammarström S, Samuelsson B. Profile of biological actions of leukotrienes C4 and D4. Acta Physiol Scand 1980; 110:331-3.
6. Drazen JM, Austen KF, Lewis RA. Clark DA, Goto G, Corey EJ. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980; 77:4354-8.
7. Dahlén S-E, Hedqvist P, Hammarström S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 1980; 288:484-6.
8. Hua X-Y, Dahlén S-E, Lundberg JM, Hammarström S, Hedqvist P. Leukotrienes C4, D4 and E4 cause extensive and widespread plasma extravasation in the guinea pig. Naunyn Schmiedebergs Arch Pharmacol 1985; 330:136-41.
9. Dahlen SE, Bjork J, Hedqvist P et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78:3887-91.
10. Echazarreta AL, Dahlén B, Garcia G et al. Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D (4) in asthma. Am J Resp Crit Care Med 2001; 164:202-6.
11. Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000; 55:7-16.
12. Creticos PS, Peters SP, Adkinson NF Jr et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984; 310:1626-30.
13. Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. New Engl J Med 1990; 323:1745-8.
14. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clin Allergy 1986; 16:289-97.
15. Okuda M, Watase T, Mezawa A, Liu CM. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988; 60:537-40.
16. Numata T, Konno A, Yamakoshi T, Hanazawa T, Terada N, Nagata H. Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy. Ann Otol Rhinol Laryngol 1999; 108:467-73.
17. O'Sullivan S, Roquet A, Dahlén B, Dahlén S-E, Kumlin M. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998; 28:1332-9.
18. Roquet A, Dahlén B, Kumlin M et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997; 155:1856-63.
19. Dahlén SE, Malmstrom K, Nizankowska E et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Resp Crit Care Med 2002; 165:9-14.
20. Dworski R, Fitzgerald GA, Cares JA, Sheller JR. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994; 149:953-9.
21. O'Shaughnessy KM, Wellings R, Gillies B, Fuller RW. Differential effects of fluticasone propionate on allergen-evoked broncho-constriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis 1993; 147:1472-6.
22. Sebaldt RJ, Sheller JR, Oates JA, Roberts LJ, FitzGerald GA. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci USA 1990; 87:6974-8.
23. Manso G, Baker AJ, Taylor IK, Fuller RW. In vivo and in vitro effects of glucocorticoids on arachidonic acid metabolism and monocyte function in humans. Eur Respir J 1992; 5:712-6.
24. Price DB, Hernandez D, Magyar P et al. Adding montelukast is at least as efficacious as doubling the budesonide dose in persistent asthma: results of the Compact study [abstract]. American Thoracic Society Annual Meeting, May 17-22, Atlanta, Georgia, 2002:A95, Poster 104.
25. Meltzer EO, Malmstrom K, Lu S et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000; 105:917-22.
26. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001; 31:61-8.
27. Philip G, Malmstrom K, Hampel FC et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002; 32:1020-8.
28. Nayak AS, Philip G, Lu S, Malice MP, Reiss TF for the Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002; 88:592-600.
29. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic Rhinitis and its Impact on Asthma. J Allergy Clin Immunol 2001; 108 (Suppl. 5):S147-334.
30. Peters-Golden M, Bailie M, Marshall T et al. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 2002; 165:229-35.